NETRIS PHARMA SAS
EIC Accelerator Winner From 2021
Inhibiting resistance to immunotherapy in Oncology by targeting Netrin-1
France
Articles
NETRIS Pharma's EIC Accelerator Funding Boosts Cancer Therapy Innovations
FranceEIC Accelerator2021
Read Article